We were proud to recently host the National Eczema Society’s Annual Medical Advisory Board (MAB) meeting, an important opportunity to bring together expert voices from across dermatology to guide our work.
Since its founding in 2021, the MAB has played a vital role in shaping our organisational strategy, research priorities, and campaigning, and we’re deeply grateful for the continued insight and commitment of its members.
This year’s meeting was an energising and collaborative session, allowing us to:
- Share updates on the eczema research projects we’re funding through our growing grants programme
- Explore emerging developments in the medical and research landscape
- Reflect on the reach and impact of the trusted health information we provide for people living with eczema
We’re also marking an important moment in the MAB’s leadership. After four years as inaugural Chair, Professor Celia Moss OBE is stepping down from the role, we’re delighted she will remain on the Board as an active member. Celia has helped to shape the MAB from the start, ensuring it reflects the needs of both clinicians and the eczema community. We are incredibly grateful for her guidance, experience and unwavering support.
We’re equally pleased to announce that Professor Carsten Flohr will now take on the role of Chair. A leading figure in eczema research and clinical care, Carsten is currently in the second year of his second three-year term on the MAB. He brings extensive academic and strategic leadership, and as head of a severe eczema clinic, he sees first-hand how devastating this condition can be.
We are hugely thankful to Professor Flohr for stepping into this important role and for the expertise he continues to share with the Society.